| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
129,180,000 |
| Market
Cap: |
1.68(B) |
| Last
Volume: |
1,683,590 |
Avg
Vol: |
1,251,834 |
| 52
Week Range: |
$4.84 - $15.18 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 8.8 |
| Insider 3/6 Months : 9.4 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile NeoGenomics operate a network of cancer-focused testing laboratories in the U.S., Europe and Asia. Co.'s testing services include the following: Cytogenetics (karyotype analysis), a study of chromosomes and their relationship to disease; Fluorescence In-Situ Hybridization, a molecular cytogenetic technique that focuses on detecting and localizing the presence or absence of specific DNA sequences and genes on chromosomes; Flow cytometry, a technique utilized to measure the characteristics of cell populations; Immunohistochemistry and Digital Imaging; Molecular testing; and Morphologic analysis, a process of analyzing cells under the microscope.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
37,900 |
113,010 |
113,010 |
| Total Buy Value |
$0 |
$212,276 |
$797,569 |
$797,569 |
| Total People Bought |
0 |
2 |
8 |
8 |
| Total Buy Transactions |
0 |
2 |
10 |
10 |
| Total Shares Sold |
43,044 |
47,962 |
47,962 |
63,925 |
| Total Sell Value |
$527,674 |
$576,854 |
$576,854 |
$825,827 |
| Total People Sold |
2 |
2 |
2 |
3 |
| Total Sell Transactions |
2 |
3 |
3 |
8 |
| End Date |
2025-10-25 |
2025-07-24 |
2025-01-23 |
2024-01-24 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Stone Warren |
Pres & Chief Operating Officer |
• – – |
2026-01-20 |
4 |
S |
$12.50 |
$276,682 |
D/D |
(22,128) |
121,631 |
|
-0% |
|
| Stone Warren |
Pres & Chief Operating Officer |
• – – |
2026-01-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,127) |
143,759 |
|
- |
|
| Stone Warren |
Pres & Chief Operating Officer |
• – – |
2026-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,382 |
158,886 |
|
- |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2026-01-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(15,145) |
75,320 |
|
- |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2026-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
59,382 |
90,465 |
|
- |
|
| Sherman Jeffrey Scott |
Chief Financial Officer |
• – – |
2025-12-07 |
4 |
D |
$0.00 |
$0 |
D/D |
(11,938) |
176,394 |
|
- |
|
| Stone Warren |
Pres & Chief Operating Officer |
• – – |
2025-12-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,776) |
99,504 |
|
- |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2025-11-25 |
4 |
AS |
$12.00 |
$250,992 |
D/D |
(20,916) |
31,083 |
|
4% |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2025-11-25 |
4 |
OE |
$10.05 |
$90,219 |
D/D |
8,977 |
51,999 |
|
- |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2025-10-16 |
4 |
AS |
$10.00 |
$49,180 |
D/D |
(4,918) |
43,022 |
|
24% |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2025-09-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,666) |
47,940 |
|
- |
|
| Sherman Jeffrey Scott |
Chief Financial Officer |
• – – |
2025-08-06 |
4 |
B |
$5.62 |
$112,322 |
D/D |
20,000 |
188,332 |
2.74 |
116% |
|
| Zook Anthony P. |
Chief Executive Officer |
• • – |
2025-08-06 |
4 |
B |
$5.58 |
$99,954 |
D/D |
17,900 |
38,066 |
2.81 |
116% |
|
| Olivo Alicia C |
EVP, GC & Business Development |
• – – |
2025-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(14) |
49,606 |
|
- |
|
| Zook Anthony P. |
Chief Executive Officer |
• • – |
2025-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,424) |
20,166 |
|
- |
|
| Zook Anthony P. |
Chief Executive Officer |
• • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
23,590 |
|
- |
|
| Gunn Neil |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
28,100 |
|
- |
|
| Williams Felicia |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,160 |
7,160 |
|
- |
|
| Perez David Brian |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
33,890 |
|
- |
|
| Kelly Michael Aaron |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
44,009 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2025-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,254 |
131,023 |
|
- |
|
| Kanovsky Stephen M |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
52,344 |
|
- |
|
| Hannah Alison L. |
Director |
– • – |
2025-06-01 |
4/A |
OE |
$0.00 |
$0 |
D/D |
12,254 |
131,023 |
|
- |
|
| Tetrault Lynn A. |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
73,652 |
|
- |
|
| Floegel Elizabeth |
Director |
– • – |
2025-06-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,254 |
23,590 |
|
- |
|
486 Records found
|
|
Page 1 of 20 |
|
|
0.28 (2.21%) 
